Related Experiment Video

Updated: Aug 15, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Richard V Parry1, Jens M Chemnitz, Kenneth A Frauwirth

  • 1Abramson Family Cancer Research Institute, 556 BRB II/III, 421 Curie Blvd., University of Pennsylvania, Philadelphia, PA 19104, USA.

Molecular and Cellular Biology
|October 18, 2005
PubMed

Insights

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed cell death protein 1 (PD-1) inhibit T-cell activation via distinct pathways. CTLA-4 utilizes PP2A, while PD-1 targets PI3K, leading to different cellular outcomes.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Biology

Background:

  • Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed cell death protein 1 (PD-1) are critical negative regulators of T-cell activation.
  • Understanding the distinct molecular mechanisms employed by CTLA-4 and PD-1 is crucial for developing effective immunotherapies.

Purpose of the Study:

  • To elucidate the separate molecular pathways through which CTLA-4 and PD-1 inhibit T-cell activation.
  • To investigate the role of specific signaling molecules and motifs in CTLA-4 and PD-1 mediated T-cell suppression.

Main Methods:

  • Comparative analysis of T-cell activation markers, glucose metabolism, and Akt phosphorylation upon CTLA-4 and PD-1 ligation.
  • Assessment of the impact of okadaic acid on CTLA-4 mediated Akt inhibition.
  • Investigation of the role of the immunoreceptor tyrosine-based switch motif in PD-1 signaling.
  • Analysis of T-cell transcriptional profiles following CD3/CD28 stimulation and receptor ligation.

Main Results:

  • Both CTLA-4 and PD-1 ligation inhibited CD3/CD28-mediated Akt activity and glucose metabolism, but through different mechanisms.
  • CTLA-4 suppression of Akt phosphorylation was sensitive to okadaic acid, implicating protein phosphatase 2A (PP2A).
  • PD-1 signaling inhibited Akt phosphorylation by blocking CD28-mediated phosphatidylinositol 3-kinase (PI3K) activation, dependent on its cytoplasmic tail motif.
  • PD-1 ligation more effectively altered the T-cell transcriptional profile compared to CTLA-4.

Conclusions:

  • CTLA-4 and PD-1 employ distinct molecular mechanisms to suppress T-cell activation.
  • CTLA-4 acts via PP2A, whereas PD-1 acts via PI3K inhibition, leading to differential cellular phenotypes.
  • These findings highlight the potential for synergistic effects when targeting both CTLA-4 and PD-1 in T-cell-based therapies.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...